LAMIVUDINE-ZIDOVUDINE TABLET

Lamivudine and Zidovudine
$0.6228per EA

Strength

150; 300 mg/1; mg/1

NDC

65862003660

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMIVUDINE; ZIDOVUDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077558

On Market Since

5/5/2017

Price History

1W

0.0%

1M

+0.9%

3M

+11.8%

6M

-12.9%

1Y

+11.3%

3Y

-22.1%

5Y

N/A

All

-36.2%